Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the five ratings firms that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, three have assigned a buy rating and one has assigned a strong buy rating […]
18 Sep 14:44 · The Markets Daily